Thrombin Inhibition Preoperatively in early breast cancer (TIP study)
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Breast cancer; Venous thromboembolism
- Focus Biomarker; Pharmacodynamics
- Acronyms TIP
- 07 Jun 2017 Biomarkers information updated
- 14 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ISCRTN:Current Controlled Trials record.
- 17 Nov 2015 According to ISCRTN:Current Controlled Trials third treatment group is added.